Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.58 USD | -0.78% | +7.34% | +182.65% |
04-04 | Avidity Biosciences Insider Sold Shares Worth $734,919, According to a Recent SEC Filing | MT |
04-04 | Avidity Biosciences Insider Sold Shares Worth $542,214, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+182.65% | 2.45B | |
-3.79% | 87.06B | |
+2.76% | 40.25B | |
-17.49% | 31.09B | |
+54.63% | 24.74B | |
-13.13% | 15.91B | |
-9.12% | 11.96B | |
-15.45% | 11.92B | |
-42.56% | 11.61B | |
+6.07% | 8.73B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Chardan Research Adjusts Price Target for Avidity Biosciences to $27 From $29, Maintains Buy Rating